Description

FLUSURE™ RTU is a liquid preparation containing 2 type-A field isolates, subtypes H1N1 and H3N2, of inactivated swine influenza viruses grown on an established cell line. FLUSURE RTU contains Amphigen^®, a unique oil-in-water adjuvant, to enhance the immune response.

Approved Uses

Vaccination of healthy swine 3 weeks of age or older as an aid in preventing respiratory disease caused by swine influenza virus (SIV) subtypes H1N1 and H3N2.

Key Features

• Proven, effective, bivalent swine-flu protection. FLUSURE™ aids in the prevention of respiratory disease caused by swine influenza (SIV) subtypes H1N1 and H3N2 — the two subtypes most often diagnosed in U.S. swine herds.
• FLUSURE bivalent vaccine is an important tool in fighting swine influenza, since immunity against H1N1 does not protect against viruses of the H3N2 subtype. This is especially important since virus typing conducted between 1998 and 2000 at leading swine diagnostics laboratories found both subtypes almost equally prevalent.
• FLUSURE was developed to cross-react with H1N1 and H3N2 field isolates currently circulating in major pig population centers of the U.S.
• The freeze-dried formulation provides for greater flexibility when dosing.
• Amphigen, the adjuvant in FLUSURE, provides for a prolonged immune response, a high degree of safety, ease of use and excellent syringability.

Packaging

50-dose vial, 250-dose vial